// App-Quantinova.ai

110 : Prevalence of oligoprogression in metastatic hormone-resistant prostate cancer patients on androgen targeted therapies: Could targeted radiotherapy improve patient outcomes?

Researchers

Presenter

  • Priyanka Patel

Principal Investigators

  • Nina Tunariu

  • Alison Tree

Medical Centers

  • Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • NCT03644303

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved